Insulet
PODD
#1018
Rank
โ‚ฌ17.90 B
Marketcap
255,29ย โ‚ฌ
Share price
3.90%
Change (1 day)
30.19%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Revenue for Insulet (PODD)

Revenue in 2024 (TTM): โ‚ฌ1.81 Billion

According to Insulet's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.89 Billion. In 2023 the company made a revenue of โ‚ฌ1.53 Billion an increase over the revenue in the year 2022 that were of โ‚ฌ1.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insulet from 2006 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ1.81 B18.08%
2023 โ‚ฌ1.53 B26.16%
2022 โ‚ฌ1.21 B25.42%
2021 โ‚ฌ0.97 B31.95%
2020 โ‚ฌ0.73 B11.58%
2019 โ‚ฌ0.65 B33.7%
2018 โ‚ฌ0.49 B27.51%
2017 โ‚ฌ0.38 B10.78%
2016 โ‚ฌ0.34 B36.14%
2015 โ‚ฌ0.25 B7.95%
2014 โ‚ฌ0.23 B32.68%
2013 โ‚ฌ0.17 B11.97%
2012 โ‚ฌ0.15 B36.29%
2011 โ‚ฌ0.11 B60.82%
2010 โ‚ฌ72.9 M58.17%
2009 โ‚ฌ46.08 M78.69%
2008 โ‚ฌ25.79 M181.64%
2007 โ‚ฌ9.15 M209.14%
2006 โ‚ฌ2.96 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ2.24 B 17.95%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.78 B-58.76%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.78 B 99.30%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.98 B 4,320.38%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ39.47 B 1,977.57%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ31.60 B 1,563.19%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ39.13 B 1,959.75%๐Ÿ‡บ๐Ÿ‡ธ USA